OTCPicks.com’s Daily Small Cap and Microcap Newsletter presents a range of the hottest small cap stocks on trading on the OTC and OTCBB markets. In addition to our Newsletters, OTCPicks.com is quickly becoming the premier community destination for small cap and microcap traders to meet up and discuss their top stock picks. Visit http://www.otcpicks.com/microcap.htm today to join this growing community.
Our Stocks to Watch today include Euoko Group Inc. (OTCBB: EUOK), MDRNA Inc. (Nasdaq: MRNA), Electro-Optical Sciences Inc. (Nasdaq: MELA), Zippi Networks Inc. (OTC: ZIPI), Insmed Inc. (Nasdaq: INSM) and DuPont Fabros Technology Inc. (NYSE: DFT).
For the complete newsletter please visit: http://www.otcpicks.com/daily-market-movers/index.php
For more in-depth coverage of small cap stocks visit http://www.otcpicks.com/microcap.htm
EUOKO GROUP INCORPORATED (OTCBB: EUOK)
Euoko Group Inc. develops, markets and distributes scientifically-advanced, innovative skin treatments for luxury and mass markets. The luxury brand, Euoko, is the company's flagship brand. Euoko's current portfolio targets the most demanding class of luxury skin care customers and consists of 25 treatments spanning five collections that offer comprehensive solutions to such skin concerns as wrinkles, fine lines, under-eye dark circles, dark spots, pigmentation concerns, acne, oxidation, environmental exposure and skin fatigue. Euoko's well-appointed, understated primary and secondary packaging communicates innovation, science, modernism and clean sophistication, while reflecting the prestige positioning of the portfolio. Euoko's products are represented through premium distribution channels in more than twenty countries and territories. Since the introduction of its products in September 2007, Euoko has achieved retail partnerships with such premium department stores as Bergdorf Goodman, Saks Fifth Avenue, Neiman Marcus, La Rinascente (Italy), Ogilvy and Andrew's (Canada), Ludwig Beck (Germany), as well as such premier retailers as Bliss (USA), a subsidiary of Starwood Hotels and Resorts. Euoko's products are also sold globally through the company's internally-operated, multi-currency, multi-lingual website (www.euoko.com) and at 1.800.98.EUOKO (US/Canada). Euoko Group Inc. operates an investor communication website at www.euokogroup.com.
MDRNA INCORPORATED (NASDAQ: MRNA)
"Up 116.69% in morning trading"
MDRNA is a biotechnology company focused on the development and commercialization of therapeutic products based on RNA interference (RNAi). Our goal is to improve human health through the development of RNAi-based compounds and drug delivery technologies that together provide superior therapeutic options for patients. Over the past decade, we have developed substantial capabilities in molecular biology, cellular biology, lipid chemistry, peptide chemistry, pharmacology and bioinformatics, which we are applying to a wide range of RNAi technologies and delivery approaches. These capabilities plus the in-licensing of key RNAi-related intellectual property have rapidly enabled us to become a leading RNAi-based therapeutics company with a pre-clinical pipeline in key therapeutic areas including oncology, metabolic disorders and inflammation. Through our capabilities, expertise and know-how, we are incorporating multiple RNAi technologies as well as peptide- and lipid-based delivery approaches into a single integrated drug discovery platform that will be the engine for our clinical pipeline as well as a versatile platform for establishing broad therapeutic partnerships with biotechnology and pharmaceutical companies. We are also investing in new technologies that we expect to lead to safer and more effective RNAi-based therapeutics while aggressively building upon our broad and extensive intellectual property estate. By combining broad expertise in siRNA science with proven delivery platforms and a strong IP position, MDRNA is well positioned as a leading RNAi-based drug discovery and development company.
ELECTRO-OPTICAL SCIENCES INCORPORATED (NASDAQ: MELA)
"Up 73.37% in morning trading"
Electro-Optical Sciences (EOS) is a medical device company focused on designing and developing a non-invasive, point-of-care instrument to assist in the early detection of melanoma. MelaFind features a hand-held imaging device that emits light of multiple wavelengths to capture images of suspicious pigmented skin lesions and extract data. Using sophisticated algorithms, the data are then analyzed against a proprietary database of melanomas and benign lesions in order to provide information to assist in the determination of whether the lesion should be biopsied.
ZIPPI NETWORKS INCORPORATED (OTC: ZIPI)
Zippi™ Networks, Inc., headquartered in San Jose, Calif., has created a revolutionary business process (three US Patents Pending), together with the ease of hand-held mobile technology, social networking, and the ability to recycle that empowers a new generation of online sellers. Founded in 2006, Zippi promises to engage consumers with an easy toll free telephone number designed to allow everyone an easy hassle free way of selling items online; by phoning 1-877-GO-ZIPPI an item owner can receive a quick "mini appraisal" through the "Ask Zippi" appraisal system. Zippi connects this appraisal with the appropriate Zipster (eBay seller) which handles the entire transaction.
INSMED INCORPORATED (NASDAQ: INSM)
"Up 17.35% in morning trading"
Insmed Inc. is a biopharmaceutical company with unique protein process development and manufacturing experience and a proprietary protein platform aimed at niche markets with unmet medical needs. For more information, visit www.insmed.com.
DUPONT FABROS TECHNOLOGY (NYSE: DFT)
"Up 12.00% in morning trading"
DuPont Fabros Technology, Inc. is a real estate investment trust (REIT) and leading owner, developer, operator and manager of wholesale data centers. The Company's data centers are highly specialized, secure facilities used primarily by national and international technology companies to house, power and cool the computer servers that support many of their most critical business processes. DuPont Fabros Technology, Inc. is headquartered in Washington, DC.
About OTCPicks.com
OTCPicks.com is fast becoming the premier Internet destination for investors seeking information on smallcap and microcap companies. The web site features companies in Profile Campaigns, Executive Interviews and Research Reports authored by our financial writers. We publish our Daily Market Movers Digest Newsletter to opt-in investor members. OTCPicks.com presents the latest information for the discerning small cap and microcap investor. The site features informative articles on microcap investing, the top penny stock picks, and a wealth of small cap research on vertical markets. To feature a company on OTCPicks.com, please contact our publisher, Brian Dean at 972-546-3740, or via email at publisher@otcpicks.com.
Forward-Looking Statement: This press release includes "forward-looking statements" within the meaning of the federal securities laws, commonly identified by such terms as "believes," "looking ahead," "anticipates," "estimates" and other terms with similar meaning. Although the Company believes that the assumptions upon which its forward-looking statements are based are reasonable, it can give no assurance that these assumptions will prove to be correct. Important factors that could cause actual results to differ materially from the Company's projections and expectations are disclosed in the Company's filings with the Securities and Exchange Commission. All forward-looking statements in this press release are expressly qualified by such cautionary statements and by reference to the underlying assumptions.
Disclosure: OTCPicks.com has been compensated three thousand dollars by a third party for EUOK advertising and promotional services.
OTCPicks.com is not a registered investment advisers or broker/dealer. OTCPicks.com makes no recommendation that the purchase of securities of companies profiled in this website is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market their securities, investing in such securities is highly speculative and carries a high degree of risk.
